Since being founded in 2011, Rutledge Cancer Foundation (RCF) is proud to have served more than 18,000 adolescents and young adults (AYAs) and their family members through Carley’s Closet new diagnosis bags, RCF Patient Outings, our Oncofertility Preservation Program and therapeutic exercise.
We’ve also funded research and clinical trials focused on more effective, less toxic therapies for sarcomas and other solid tumor cancers with the goal of allowing AYA patients to live longer, healthier lives.
Since 2011…
Family and friends hosted the first Gold Ribbon Kickball Game, raising $23,000 for sarcoma research at Georgetown University and $15,000 for a dedicated Teen Room at Cook Children's Medical Center in Fort Worth.
Carley's Closet is established at Cook Children's and MD Anderson Medical Centers, providing bags filled with age-appropriate items to comfort and entertain newly diagnosed AYA cancer patients in the hospital.
Carley J. Rutledge Sarcoma Foundation was established as a 501(c)(3), later becoming Rutledge Cancer Foundation.
RCF began hosting patient outings to help build connections and a community with others on the same cancer journey.
RCF helps push forward the development of Ewing Sarcoma targeted drug vaccine therapies at Mary Crowley Cancer Research Center.
RCF began work with UNT Health Science Center studying a novel nanoparticle that could target cancer cells and deliver drug payloads with minimal toxicity.
RCF and Moncrief Cancer Institute worked together to develop the first ever community-wide Oncofertility preservation program in the United States.
FWZA held its first annual Zoo Ball fundraising gala following the opening of the elephant house.
FWZA assumes construction management on the new World of Primates habitat and payroll to ensure the project is completed on time and within budget for the public.
RCF funds Children's Cancer Therapy Development Institute in Beaverton, Oregon to develop pediatric cell lines for ASPS, a rare pediatric sarcoma.
RCF partners with R4 Foundation to establish and fund FitSteps for Life (now ForeverFit), a therapeutic cancer exercise program in Fort Worth at UNT Health Science Center.
RCF creates a collaboration between Jason Yustein, MDPhD, Lab at Baylor College of Medicine and Greg Aune, MDPhD, Lab at UT San Antonio and a partnership with Qana Therapeutics in Austin, Texas, to continue research of novel nanoparticle delivery mechanism for Ewing sarcoma. New research team receives an NIH R21 Grant to continue development of Nanoparticle Drug Delivery in pediatric sarcomas.
RCF supports research of Drs. Pete Anderson and Timothy Chan at Cleveland Clinic to develop an mRNA Vaccine and CarT Therapy for Ewing sarcoma.
Since 2011, RCF has funded over $2,600,000 in research for less toxic, more curative therapies for sarcomas and other solid tumor cancers and programs that ease the impact of AYA cancers.
RCF began supporting Dr. Poul Sorensen at BC Cancer Molecular Oncology Research, Provincial Health Services Authority, Vancouver, BC, Targeting IL1RAP surface protein with novel immunotherapy approaches for Ewing sarcoma.
